Vestal Point Capital, LP
Annual return '25
+33.9%
SPY '25
+17.7%
Alpha
+16.2ptsvs SPY
Invested
$3.6B
Holdings
96
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 96%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$RVMD
Revolution Medicines Inc
Held since at least Q1 2024
6.5%
02
$BMRN
BioMarin Pharmaceutical Inc
Held since at least Q1 2024
5.6%
03
$ABVX
Abivax SA
Held since at least Q1 2024
4.7%
04
$NBIX
Neurocrine Biosciences Inc
Held since at least Q1 2024
4.6%
05
$ARWR
Arrowhead Pharmaceuticals Inc
Held since at least Q1 2024
4.0%
06
$ELVN
Enliven Therapeutics Inc
Held since at least Q1 2024
3.6%
07
$RGEN
Repligen Corp
Held since at least Q1 2024
3.0%
08
$BCAX
Bicara Therapeutics Inc
Held since at least Q1 2024
3.0%
09
$NRIX
Nurix Therapeutics Inc
Held since at least Q1 2024
2.8%
10
$APGE
Apogee Therapeutics Inc
Held since at least Q1 2024
2.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:28 UTC.